Pipeline of Non-Small Cell Lung Cancer Market Review Research for H2 2016

USA - English

• India - English

PUNE, India, February 2, 2017 /PRNewswire/ --

ReportsnReports.com adds "Non-Small Cell Lung Cancer - Pipeline Review, H2 2016" to its store providing comprehensive information on the therapeutics under development for Non-Small Cell Lung Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Browse 229 market data tables and 17 figures; spread across 2236 pages is available at http://www.reportsnreports.com/reports/797760-non-small-cell-lung-cancer-pipeline-review-h2-2016.html.

Companies discussed in this Non-Small Cell Lung Cancer Pipeline Review, H2 2016 report include 3-V Biosciences Inc, 3SBio Inc, 4SC AG, AbbVie Inc, Ability Pharmaceuticals SL, ACEA Biosciences Inc, Acetylon Pharmaceuticals Inc, Adamed Sp z oo, Adaptimmune Therapeutics Plc, Advanced Cancer Therapeutics, Advantagene Inc, Advenchen Laboratories LLC, Allist Shanghai Pharmaceutical Technology Co Ltd, Almac Discovery Ltd, Altimmune Inc, Altor BioScience Corp, Amgen Inc, Andarix Pharmaceuticals Inc, AndroScience Corp, Apac Biotech Pvt Ltd, APO-T BV, Aptevo Therapeutics Inc, Aptose Biosciences Inc, Argos Therapeutics Inc, Ariad Pharmaceuticals Inc, ARMO Biosciences Inc, Arog Pharmaceuticals Inc, ArQule Inc, Array BioPharma Inc, Arrien Pharmaceuticals LLC, Asana BioSciences LLC, Astellas Pharma Inc, Asterias Biotherapeutics Inc, Astex Pharmaceuticals Inc, AstraZeneca Plc, ATLAB Pharma SAS, Atreca Inc, Aurigene Discovery Technologies Ltd, AVEO Pharmaceuticals Inc, Axelar AB, Azaya Therapeutics Inc, Basilea Pharmaceutica Ltd, Batu Biologics Inc, Bavarian Nordic A/S, Bayer AG, BeiGene Ltd, BerGenBio AS, Beta Pharma Inc, Betta Pharmaceuticals Co Ltd, BeyondSpring Pharmaceuticals Inc, Bio-Path Holdings Inc, Biocad, BioCancell Ltd, Biocon Ltd, BioLineRx Ltd, Bionovis SA, Biothera Pharmaceutical Inc, Blueprint Medicines Corp, Boehringer Ingelheim GmbH, Boston Biomedical Inc, Bristol-Myers Squibb Company, Calithera Biosciences Inc etc.

Order a Purchase Copy of this Report @ http://www.reportsnreports.com/purchase.aspx?name=797760.

Scope of this report: The report provides a snapshot of the global therapeutic landscape of Non-Small Cell Lung Cancer and reviews pipeline therapeutics for Non-Small Cell Lung Cancer by companies and universities/research institutes based on information derived from company and industry-specific sources and key players involved Non-Small Cell Lung Cancer therapeutics and enlists all their major and minor projects. The research covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages. The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities and assesses Non-Small Cell Lung Cancer therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report summarizes all the dormant and discontinued pipeline projects with latest news related to pipeline therapeutics for Non-Small Cell Lung Cancer.

Another newly published market research report titled on Parkinson's Disease - Pipeline Review, H2 2016 (http://www.reportsnreports.com/reports/797759-parkinsons-disease-pipeline-review-h2-2016.html) provides comprehensive information on the therapeutic development for Parkinson's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. Companies Involved in Therapeutics Development are 2-BBB Medicines BV, 4P Therapeutics LLC, AbbVie Inc, AC Immune SA, Acelot Inc, Acorda Therapeutics Inc, Adamas Pharmaceuticals Inc, Addex Therapeutics Ltd, Advinus Therapeutics Ltd, Aeolus Pharmaceuticals Inc, AFFiRiS AG, Amabiotics SAS, Amarantus Bioscience Holdings Inc, American Gene Technologies International Inc, Anavex Life Sciences Corp, Angita BV, Antoxis Ltd etc.

Explore more reports on Pharmaceuticals Market http://www.reportsnreports.com/market-research/pharmaceuticals/.

About Us: 

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel: +1-888-391-5441
[email protected]

Connect with Us:  

LinkedIn: http://www.linkedin.com/company/reportsnreports

RSS/Feeds: http: //http://www.reportsnreports.com/feed/l-latestreports.xml

SOURCE ReportsnReports